布里氏评分
逻辑回归
人工智能
加权
机器学习
试验装置
随机森林
特征选择
医学
数据集
计算机科学
接收机工作特性
班级(哲学)
水准点(测量)
集合(抽象数据类型)
管道(软件)
校准
F1得分
模式识别(心理学)
肌筋膜疼痛综合征
回顾性队列研究
数学
支持向量机
物理疗法
选择(遗传算法)
试验数据
算法
统计分类
统计
点(几何)
病历
训练集
作者
Hang Yu,Lelan Yang,Xiaoyang Zhao
标识
DOI:10.1038/s41598-026-80511-3
摘要
Class imbalance may distort performance estimates in clinical prediction models for myofascial pelvic pain syndrome (MPPS). To compare class weighting, categorical-aware synthetic oversampling, and constrained generative augmentation for contemporaneous classification of MPPS. The retrospective single-center dataset contained 2016 records (568 MPPS and 1448 health-examination controls) and 23 predictors. Exact duplicate predictor signatures were kept in the same partition, producing a development set of 1409 records (397 MPPS) and an untouched test set of 607 records (171 MPPS). Logistic Regression and XGBoost were evaluated with original data, class weighting, SMOTENC, and a constrained tabular GAN. Five-by-three nested cross-validation, calibration, and threshold selection were confined to the development set. Both augmentation methods balanced each fold-training subset to 1:1. Constrained-GAN XGBoost had a test ROC-AUC of 0.852 (95% CI 0.813–0.886), compared with 0.846 (0.808–0.884) for class-weighted XGBoost; the absolute difference was 0.006 (Holm-adjusted p = 0.002). Their PR-AUC estimates were 0.749 (0.694–0.801) and 0.747 (0.686–0.808), respectively. The GAN pipeline had a Brier score of 0.128 (0.111–0.144) versus 0.130 (0.116–0.144), whereas the calibration intercept was closer to zero for class weighting (− 0.013, − 0.171 to 0.172) than for GAN augmentation (− 0.174, − 0.319 to -0.006). Across five algorithmic seeds, GAN-XGBoost had slightly higher mean ROC-AUC (0.856 versus 0.849), while class-weighted XGBoost had slightly higher mean accuracy (0.779 versus 0.776). XGBoost outperformed Logistic Regression. GAN augmentation produced slightly higher discrimination point estimates, but class weighting was comparable across calibration, decision-curve, and threshold-dependent measures. These internal results do not establish overall clinical superiority and require external validation in symptomatic populations.
科研通智能强力驱动
Strongly Powered by AbleSci AI